The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI
Rida Rehman, Albrecht Fröhlich, Florian olde Heuvel, Lobna Elsayed, Tobias M. Boeckers, Markus Stefan Huber-Lang, Maria Cristina Morganti-Kossmann, Francesco Roselli
This study shows that FGFR inhibition with Rogaratinib reduces microglia reactivity and synaptic loss in TBI by dampening neuroimmunological responses.
Frontiers in Immunology · Nov 20, 2024Peer-reviewedNeuroscience